Original Data

The Diterpene Glycoside, Rebaudioside A, Does not Improve Glycemic Control or Affect Blood Pressure After Eight Weeks Treatment in the Goto-Kakizaki Rat

Stig E.U. Dyrskog¹, Per B. Jeppesen¹, Jianguo Chen¹, Lars P. Christensen², Kjeld Hermansen¹

Keywords: type 2 diabetes, rats, rebaudioside A, glycemic control, blood pressure

Abstract

The plant, Stevia rebaudiana Bertoni (SrB), has been used for the treatment of diabetes in traditional medicine. Previously, we have demonstrated that long-term administration of the glycoside stevioside has insulinotropic, glucagonostatic, anti-hyperglycemic and blood pressure-lowering effects in type 2 diabetic animal models. The aim of this study was to elucidate if long-term administration of rebaudioside A, another glycoside isolated from the plant SrB, could improve glycemic control and lower blood pressure in an animal model of type 2 diabetes. We divided male Goto-Kakizaki (GK) rats into two groups which were fed a standard laboratory chow diet for eight weeks. The diet was supplemented with oral rebaudioside A (0.025 g/kg BW/day) in the experimental group. Blood glucose, weight, blood pressure and food intake were measured weekly. Animals were equipped with an intra-arterial catheter, and at week eight the conscious rats underwent an intra-arterial glucose tolerance test (IAGTT) (2.0 g/kg BW). During the IAGTT, the level of glucose, glucagon, and insulin responses did not differ significantly between the two groups. Fasting levels of glucose, glucagon, insulin or levels of blood lipids did not differ between the groups throughout the study period. We observed no effect on blood pressure or weight development. In conclusion, oral supplementation with rebaudioside A (0.025 g/kg BW/day) for eight weeks did not influence blood pressure or glycemic control in GK rats. Rebaudioside A failed to show the beneficial effects in diabetic animals previously demonstrated for stevioside.

Fulltext: HTML , PDF (316KB)

This article has been cited by other articles:

	Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats Misra H, Soni M, Silawat N, Mehta D, Mehta BK, Jain DC J Pharm Bioallied Sci 2011. 3(2):242-248
	Hypotensive action of naturally occurring diterpenes: a therapeutic promise for the treatment of hypertension Tirapelli CR, Ambrosio SR, de Oliveira AM, Tostes RC Fitoterapia 2010. 81(7):690-702
	The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents Tolstikova TG, Khvostov MV, Bryzgalov AO Mini Rev Med Chem 2009. 9(11):1317-1328
	Safety evaluation of certain food additives World Health Organization WHO Food Additives Series 60, 2009. Geneva
	Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus Maki KC, Curry LL, Reeves MS, Toth PD, McKenney JM, Farmer MV, Schwartz SL, Lubin BC, Boileau AC, Dicklin MR, Carakostas MC, Tarka SM Food Chem Toxicol 2008. 46(7):S47-S53
	The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure Maki KC, Curry LL, Carakostas MC, Tarka SM, Reeves MS, Farmer MV, McKenney JM, Toth PD, Schwartz SL, Lubin BC, Dicklin MR, Boileau AC, Bisognano JD Food Chem Toxicol 2008. 46(7):S40-S46
	Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K(+)-channels Abudula R, Matchkov VV, Jeppesen PB, Nilsson H, Aalkjær C, Hermansen K Diabetes Obes Metab 2008. 10(11):1074-1085
	A 90-day oral (dietary) toxicity study of rebaudioside a in sprague-dawley rats Nikiforov AI, Eapen AK Int J Toxicol 2008. 27(1):65-80
	Can Stevioside in Combination with a Soy-Based Dietary Supplement Be a New Useful Treatment of Type 2 Diabetes? An In Vivo Study in the Diabetic Goto-Kakizaki Rat Jeppesen PB, Dyrskog SE, Agger A, Gregersen S, Colombo M, Xiao J, Hermansen K Rev Diabet Stud 2006. 3(4):189-199